According to a report in The International Journal of Oncology, giving low dose naltrexone (LDN)  to cancer patients can improve the immune system’s ability to kill cancerous cells, as well as improve the efficacy of standard cancer treatments and immunotherapy. This major breakthrough gives research credence to what some doctors have observed in their cancer … Continue reading LDN Treatment Helps to Kill Cancer Cells